Evidence map›Paper›PMID 33320356›Full record

ArticleThe EMBO journal2021

Modulation of Yorkie activity by alternative splicing is required for developmental stability.

Diwas Srivastava, Marion de Toledo, Laurent Manchon, Jamal Tazi, François Juge

Abstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diwas SrivastavaInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-2287-4908
Marion de ToledoInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-7638-0041
Laurent ManchonInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.ORCID 0000-0001-9242-4385
Jamal TaziInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
François JugeInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.ORCID 0000-0001-5015-2019

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Hippo signaling pathway is a major regulator of organ growth, which controls the activity of the transcription coactivator Yorkie (Yki) in Drosophila and its homolog YAP in mammals. Both Yki and YAP proteins exist as alternatively spliced isoforms containing either one or two WW domains. The biological importance of this conserved alternative splicing event is unknown. Here, we identify the splicing factor B52 as a regulator of yki alternative splicing in Drosophila and show that B52 modulates growth in part through modulation of yki alternative splicing. Yki isoforms differ by their transcriptional activity as well as their ability to bind and bridge PPxY motifs-containing partners, and can compete in vivo. Strikingly, flies in which yki alternative splicing has been abrogated, thus expressing only Yki2 isoform, exhibit fluctuating wing asymmetry, a signal of developmental instability. Our results identify yki alternative splicing as a new level of modulation of the Hippo pathway, that is required for growth equilibration during development. This study provides the first demonstration that the process of alternative splicing contributes to developmental robustness.

Indexed as

Alternative SplicingAnimalsCell LineDrosophila melanogasterDrosophila ProteinsGene Expression Regulation, DevelopmentalGene Knockdown TechniquesNuclear ProteinsProtein BindingProtein DomainsRNA Splicing FactorsSequence Analysis, RNATrans-ActivatorsWings, AnimalYAP-Signaling ProteinsB52 protein, DrosophilaDrosophila ProteinsNuclear ProteinsRNA Splicing FactorsTrans-ActivatorsYAP-Signaling ProteinsYki protein, Drosophilaalternative splicingdevelopmental stabilitygrowthhippo pathway

Identifiers

PMID33320356
PMCPMC7849169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.